Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter
about
Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent mannerCdc2: a monopotent or pluripotent CDK?Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complexMOZ and MORF, two large MYSTic HATs in normal and cancer stem cellsRepression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNAHistone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolarsRunx-dependent expression of PKC is critical for cell survival in the sea urchin embryoHDAC and HDAC Inhibitor: From Cancer to Cardiovascular DiseasesHistone deacetylase 6 plays a role as a distinct regulator of diverse cellular processesTranscriptional regulatory cascades in Runx2-dependent bone developmentFeeding blueberry diets in early life prevent senescence of osteoblasts and bone loss in ovariectomized adult female ratsHistone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fatRegulation of gene expression in osteoblasts.The role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesisMice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST)Histone deacetylases and cancerThe RUNX genes: gain or loss of function in cancerTransforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradationMSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCsHistone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionThe interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiationBone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements inHDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repressionLymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoterHistone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.ChIP Display: novel method for identification of genomic targets of transcription factors.FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.A positive role of microRNA-15b on regulation of osteoblast differentiation.Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.Class II histone deacetylases: from sequence to function, regulation, and clinical implication.Transcription factor co-repressors in cancer biology: roles and targetingTranscription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer.The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts.RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia.Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes.
P2860
Q24300259-F1F4AE4E-6971-497C-A54F-D7742A9C59FCQ24300976-CE4F5A68-F82E-48FB-855E-3043410DFB05Q24337385-178469FE-3BD0-464A-8E67-BE12C71EA0B9Q24570117-08FF51BB-161F-46B8-B2F9-49B06614560DQ24641909-28C9FA89-1611-4DB4-B379-F8D011FD3207Q24673733-A82DBEAD-842D-46E4-90D9-D0C51881CDB3Q24675955-0F522932-AC47-4C52-A536-6574E1646EF4Q24813683-C2396B53-7819-46D6-B178-553C4B15A883Q26766640-D34E4A2A-716C-43BA-BB82-7A8DA93CFF37Q26830233-DAFC4A96-622A-4EDC-9A4B-6CD3D41EE0B9Q26830666-C5D45C69-4B04-4BBE-A47E-009BCE8847E1Q27321174-BB24F891-B74D-4F0B-A97E-F8C7E72B04C9Q27324052-79B31C13-B56C-4F47-82A6-1FD09ECF3590Q27691363-EE69A3C5-BFD3-48EE-8D7B-011918F32AE6Q27691375-5AE47975-47C3-48D7-8D6F-A72E9BD4C8A4Q27919716-B6F087B1-57D2-4DE3-8C10-CDFA3DBCF81BQ28240192-479129B3-C71E-4335-9C35-6A7C8F41B49CQ28240447-8C9254D5-83DA-42E8-B7E8-FDA857363530Q28247901-415724DF-FA64-40FE-9CF4-91D5B8CC88D4Q28261166-0A4A6680-8D20-4AE4-857C-62A951451098Q28484364-D2FBB64E-EC77-4E04-AEC4-BF0FE78C297FQ28505369-0AF6A132-482C-4FBB-9E44-F9960D6C9E6EQ28506894-9E7E0CF5-6E3C-4651-9E63-58217CA54D58Q28507461-5BAD116F-0BBD-4899-9182-90949404BF8FQ28574779-8636C0AA-E991-4940-B3EE-3B4BD68F23D7Q28582316-D0DDE68E-03AC-46EB-87C1-6E38DF1E6CBDQ28593503-E1A8435C-980E-4A7D-AE1F-74ADD228A295Q30570559-C7C2F086-1B55-4DF6-9086-0982377A3D15Q33340217-EE5198DA-FDB6-4DF8-BA89-39CA441B4876Q33661959-3AE893B5-1842-41DB-A675-3586D53B3800Q33685408-81655BE7-C67C-4C3F-A6CA-634BBD8D200EQ33705588-9C02A7A6-E3EB-48B6-AB97-1043E6DBDD1EQ33724483-9FEAF370-62CB-4C3B-AA96-0C3501B7FDA7Q33762000-41494F3F-1A8F-4D34-B239-D6079C689B13Q33823421-3076E379-3D2A-4450-AB26-1FFFF04C01D2Q33829390-E299D434-5ECB-4EBB-B136-9219581939A2Q33953806-A7E50BEE-FE6D-4C6B-959E-3C4966CB7497Q34042783-2480E4CB-EFDE-4206-8FEC-DBAC3C465ECDQ34100430-3BDE4E01-EB88-4D70-B20B-56C2E1E1C80FQ34217226-C8F3223A-D322-4435-B4F8-3319DFDE7797
P2860
Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@ast
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@en
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@nl
type
label
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@ast
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@en
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@nl
prefLabel
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@ast
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@en
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@nl
P2093
P2860
P1476
Runx2 (Cbfa1, AML-3) interacts ...... es the p21(CIP1/WAF1) promoter
@en
P2093
André J van Wijnen
Gary S Stein
Jane B Lian
Jennifer J Westendorf
Jonathan E Cascino
Rachel Kahler
Xiaodong Li
P2860
P304
P356
10.1128/MCB.22.22.7982-7992.2002
P407
P577
2002-11-01T00:00:00Z